Overview

A Study to Assess the Relative Bioavailability and Effect of Food on the Coated Granule Formulation of Mitapivat in Healthy Participants

Status:
Completed
Trial end date:
2020-12-03
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the relative bioavailability of the mitapivat coated granule formulation compared to the tablet formulation following a single oral dose of mitapivat under fasted conditions in healthy adult participants.
Phase:
Phase 1
Details
Lead Sponsor:
Agios Pharmaceuticals, Inc.